Results 31 to 40 of about 6,009 (196)
Targeted therapy for breast cancer prevention. [PDF]
With a better understanding of the etiology of breast cancer, molecularly targeted drugs have been developed and are being testing for the treatment and prevention of breast cancer.
Brown, Powel H +2 more
core +2 more sources
Triggering of Suicidal Erythrocyte Death by Bexarotene
Background/Aims: The retinoid X receptor agonist bexarotene is utilized for the treatment of cutaneous T-cell lymphoma and is effective in several further malignancies.
Abdulla Al Mamun Bhuyan +3 more
doaj +1 more source
The retinoid X receptor agonist bexarotene promotes remyelination in patients with multiple sclerosis. Murine studies have also demonstrated that RXR agonists have anti-inflammatory effects by enhancing the ability of all-trans-retinoic acid (atRA) to ...
Christopher M. Gaunt +10 more
doaj +1 more source
Gene-environment interactions due to quantile-specific heritability of triglyceride and VLDL concentrations. [PDF]
"Quantile-dependent expressivity" is a dependence of genetic effects on whether the phenotype (e.g., triglycerides) is high or low relative to its distribution in the population.
Williams, Paul T
core +1 more source
Early Treatment Critical: Bexarotene Reduces Amyloid-Beta Burden In Silico. [PDF]
Amyloid-beta peptides have long been implicated in the pathology of Alzheimer's disease. Bexarotene, a drug approved by the U.S. Food and Drug Administration for treating a class of non-Hodgkin's lymphoma, has been reported to facilitate the removal of ...
Joseph Rosenthal +2 more
doaj +1 more source
Classical dendritic cells mediate fibrosis directly via the retinoic acid pathway in severe eye allergy [PDF]
Fibrosis is a shared end-stage pathway to lung, liver, and heart failure. In the ocular mucosa (conjunctiva), fibrosis leads to blindness in trachoma, pemphigoid, and allergy.
Ahadome, SD +6 more
core +1 more source
Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study
Central hypothyroidism and dyslipidemia are well-known adverse events (AEs) of bexarotene therapy. Although hypothyroidism is known to cause dyslipidemia, no study has examined the association between hypothyroidism and dyslipidemia in patients ...
Katsunori Manaka +28 more
doaj +1 more source
Regulation of lineage specification and differentiation in embryonic stem (ES) cells can be achieved through the activation of endogenous signaling, an avenue for potential application in regenerative medicine.
Katherine Dixon, Jihong Chen, Qiao Li
doaj +1 more source
Bexarotene-Induced Hypertriglyceridemia: A Case Report
We present a case of a patient with cutaneous T-cell lymphoma started on bexarotene 300 mg/m2 due to progressing disease. The patient experienced good clinical response, but unfortunately, she developed rapid and profound hypertriglyceridemia.
Chris Maminakis +2 more
doaj +1 more source
Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice [PDF]
BACKGROUND: Though the precise cause(s) of Alzheimer’s disease (AD) remain unknown, there is strong evidence that decreased clearance of β-amyloid (Aβ) from the brain can contribute to the disease.
Alena V Savonenko +6 more
core +1 more source

